7 years of revenue, profit, cash flow and balance-sheet history through FY2026,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 25.5% per year over the past 5 years.
Net income has grown faster than revenue (31.3% vs 25.5% per year).
Operating margin has expanded, at 33.3% in the latest year.
Free cash flow has grown 31.6% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2026
$645M
$196M
89.1%
33.3%
$326M
—
$219M
2025
$570M
$223M
90.2%
39.9%
$273M
—
$210M
2024
$475M
$148M
89.3%
34.5%
$184M
—
$97M
2023
$419M
$113M
87.2%
29.9%
$178M
—
$158M
2022
$344M
$155M
88.4%
33.0%
$125M
—
$113M
2021
$207M
$50M
84.9%
25.8%
$83M
—
$66M
2020
$116M
$30M
87.2%
19.0%
$26M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$145M
$19M
86.7%
17.1%
—
—
$219M
Dec '25
$185M
$62M
89.9%
38.9%
—
—
$65M
Sep '25
$169M
$62M
90.3%
37.8%
—
—
$169M
Jun '25
$146M
$53M
89.2%
37.4%
—
—
$137M
Mar '25
$138M
$62M
89.5%
35.2%
$98M
—
$210M
Dec '24
$169M
$75M
91.6%
47.4%
$65M
—
$165M
Sep '24
$137M
$44M
90.0%
38.8%
$68M
—
$184M
Jun '24
$127M
$41M
89.3%
36.4%
$41M
—
$111M
Mar '24
$118M
$41M
89.4%
35.5%
$64M
—
$97M
Dec '23
$135M
$48M
91.0%
43.3%
$50M
—
$123M
Sep '23
$114M
$31M
88.8%
29.7%
$13M
—
$108M
Jun '23
$108M
$28M
87.9%
27.4%
$57M
—
$307M
Mar '23
$111M
$31M
87.7%
29.6%
$47M
—
$158M
Dec '22
$115M
$33M
88.3%
33.4%
$48M
—
$136M
Sep '22
$102M
$26M
87.1%
31.4%
$39M
—
$74M
Jun '22
$91M
$22M
85.6%
23.9%
$44M
—
$110M
Mar '22
$94M
$37M
87.4%
29.8%
$46M
—
$113M
Dec '21
$98M
$56M
88.7%
36.6%
$27M
—
$85M
Sep '21
$79M
$36M
88.7%
31.4%
$19M
—
$80M
Jun '21
$73M
$26M
89.0%
34.2%
$33M
—
$594M
Valuation over time
How the market has priced DOCS against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 52.5× (Mar '23) to 18.5× (Jun '26).
The price-to-sales ratio has fallen from 14.1× (Mar '23) to 5.6× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is DOCS growing its revenue and profit?
Over the past 5 years, Doximity, Inc.'s revenue has grown 25.5% per year, and net income grown 31.3% per year. These are computed facts, not advice.
How much debt does DOCS have?
As of FY2026, Doximity, Inc. reported — of total debt against $219M of cash.
What is DOCS's profit margin?
In FY2026, gross margin was 89.1%, operating margin 33.3%, and net margin 30.4%.
What is DOCS's P/E ratio?
As of Jun '26, Doximity, Inc. traded at a price-to-earnings ratio of about 18.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.